RestorGenex Names Stephen M. Simes as Chief Executive Officer
GlobeNewswire - Mon Mar 10, 6:13AM CDT
RestorGenex (OTCBB:SMDID) announced today that it has named Stephen M. Simes as its Chief Executive Officer, to lead the company. Mr. Simes formerly served as vice chairman, president, and CEO at BioSante Pharmaceuticals, Inc., a publicly held pharmaceutical company focused on developing products for women's and men's health and oncology that merged with ANI Pharmaceuticals, Inc. in 2013.
Stratus Media Group Announces Name Change to RestorGenex and Reverse Split
GlobeNewswire - Fri Mar 07, 3:00PM CST
Stratus Media Group, Inc., (OTCBB:SMDI) announced today a name change to RestorGenex Corporation (RestorGenex), as well as a 1 for 100 reverse split of its common stock. Both corporate actions were approved previously by the company's stockholders.
Stratus Media Group Acquires Paloma Pharmaceuticals, Inc. and VasculoMedics, Inc.
GlobeNewswire - Thu Mar 06, 6:30AM CST
Stratus Media Group, Inc., (OTCBB:SMDI) announced today the acquisition, through merger, of two biotechnology companies, Paloma Pharmaceuticals, Inc. and VasculoMedics, Inc. With these acquisitions, Stratus, which will be renamed RestorGenex, plans to create a world-class pharmaceutical company with an initial focus on dermatology, ocular diseases and women's health. The merger agreements were approved by the boards of directors of all companies and are expected to close following the satisfaction of certain closing conditions.
Stratus Media Group, Inc. Retains Investment Banking Firm Maxim Group LLC
Business Wire - Mon Aug 26, 9:26AM CDT
Stratus Media Group, Inc. (OTCQB:SMDI), announced today that it had retained leading investment banking, securities and investment management firm, Maxim Group LLC, to provide financial advisory and investment banking services. Maxim will focus on assisting Stratus in its strategies for maximizing shareholder value through its full scope of investment banking services.